Marc Van den Eynde

10PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Integrated Assessment of Skeletal Muscle Quantity and Quality Is Associated with Survival in Patients with Oesophagogastric Malignancies: A Retrospective Cohort Study.

|Jun 10, 2026
Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

|Nov 27, 2025
Current Management of Locally Advanced Esophageal and Esophagogastric Junction Cancers: Clinical Evidence and Evolving Strategies.

Andrea Di Donato, Marc Van den Eynde

|Nov 25, 2025
TREX1, a predator for treating MSI-H tumors?

Elena Benidovskaya, Joséphine Deneft, Marc Van den Eynde

|Aug 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.

Joseph Willis, Robert A Anders, Toshihiko Torigoe

|May 16, 2023
Implications of the Organ-Specific Immune Environment for Immune Priming Effect of Radiotherapy in Metastatic Setting.

Julien Pierrard, Geneviève Van Ooteghem, Marc Van den Eynde

Pageof 2

Frequent Collaborators

4 joint publications

Bernhard Mlecnik

3 joint publications

Gabriela Bindea

3 joint publications

Fabiana Tatangelo

3 joint publications

Toshihiko Torigoe